Strategic Investment Solutions, Inc. /Il Age X Therapeutics, Inc. Transaction History

Strategic Investment Solutions, Inc. /Il

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 29, 2024	BUY	N/A	100 Added 66.67%	250 $405,000
Q4 2023 Feb 13, 2024	SELL	$0.33 - $0.74 $3,069 - $6,882	-9,300 Reduced 98.41%	150 $58,000
Q3 2023 Nov 14, 2023	BUY	$0.67 - $0.85 $6,231 - $7,905	9,300 Added 6200.0%	9,450 $7.11 Million
Q1 2023 May 15, 2023	BUY	$0.56 - $0.8 $84 - $120	150 New	150 $99,000

Ticker AGE
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,945,100
Description
AgeX Therapeutics, Inc., a biotechnology company, focuses on the development and commercialization of novel therapeutics targeting human aging and degenerative diseases in the United States. The company's lead cell-based therapeutic candidates in development include AGEX-BAT1, a cell therapy product candidate for the treatment of various age-rel...

Get notified when there are updates to the investment portfolio of Strategic Investment Solutions, Inc. /Il, based on Form 13F filings with the SEC.

Stay updated on Strategic Investment Solutions, Inc. /Il with notifications on news.